Bertagna A - Search Results

1

Growth hormone responses to pyridostigmine in normal adults and in normal and short children.

Ghigo E, Mazza E, Imperiale E, Molinatti P, Bertagna A, Camanni F, Massara F. Ghigo E, et al. Among authors: bertagna a. Clin Endocrinol (Oxf). 1987 Dec;27(6):669-73. doi: 10.1111/j.1365-2265.1987.tb02950.x. Clin Endocrinol (Oxf). 1987. PMID: 3331977 Clinical Trial.

2

Vertebral bone density in non-amenorrhoeic hyperprolactinaemic women.

Ciccarelli E, Savino L, Carlevatto V, Bertagna A, Isaia GC, Camanni F. Ciccarelli E, et al. Among authors: bertagna a. Clin Endocrinol (Oxf). 1988 Jan;28(1):1-6. doi: 10.1111/j.1365-2265.1988.tb01195.x. Clin Endocrinol (Oxf). 1988. PMID: 3168298

3

Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes.

Martina V, Tagliabue M, Maccario M, Bertagna A, Ghigo E, Massara F, Camanni F. Martina V, et al. Among authors: bertagna a. Horm Metab Res. 1987 Sep;19(9):449-50. doi: 10.1055/s-2007-1011850. Horm Metab Res. 1987. PMID: 3692441 No abstract available.

4

Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans.

Arvat E, Gianotti L, Ramunni J, Grottoli S, Brossa PC, Bertagna A, Camanni F, Ghigo E. Arvat E, et al. Among authors: bertagna a. Eur J Endocrinol. 1995 Sep;133(3):300-4. doi: 10.1530/eje.0.1330300. Eur J Endocrinol. 1995. PMID: 7581945

5

Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women.

Arvat E, Gianotti L, Broglio F, Maccagno B, Bertagna A, Deghenghi R, Camanni F, Ghigo E. Arvat E, et al. Among authors: bertagna a. Eur J Endocrinol. 1997 May;136(5):483-7. doi: 10.1530/eje.0.1360483. Eur J Endocrinol. 1997. PMID: 9186268 Clinical Trial.

6

Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Mazza E, Maccario M, Ramunni J, Gauna C, Bertagna A, Barberis AM, Patroncini S, Messina M, Ghigo E. Mazza E, et al. Among authors: bertagna a. J Endocrinol Invest. 1999 Oct;22(9):681-7. doi: 10.1007/BF03343629. J Endocrinol Invest. 1999. PMID: 10595831

7

Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.

Ghigo E, Pogliano G, Campagnoli C, Bertagna A, Camanni F, Massara F. Ghigo E, et al. Among authors: bertagna a. J Endocrinol Invest. 1984 Oct;7(5):525-7. doi: 10.1007/BF03348462. J Endocrinol Invest. 1984. PMID: 6439773

8

Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.

Ciccarelli E, Grottoli S, Razzore P, Gaia D, Bertagna A, Cirillo S, Cammarota T, Camanni M, Camanni F. Ciccarelli E, et al. Among authors: bertagna a. J Endocrinol Invest. 1997 Oct;20(9):547-51. doi: 10.1007/BF03348017. J Endocrinol Invest. 1997. PMID: 9413809

9

Effect of pirenzepine on apomorphine-induced growth hormone secretion in man.

Massara F, Tangolo D, Demislis K, Goffi S, Bertagna A, Molinatti GM. Massara F, et al. Among authors: bertagna a. Panminerva Med. 1984 Jul-Sep;26(3):167-9. Panminerva Med. 1984. PMID: 6549208 No abstract available.

10

Pituitary computed tomography and dynamic tests of prolactin and thyrotropin secretion in 103 hyperprolactinemic patients.

Ciccarelli E, Ghigo E, Mazza E, Gandini G, Avataneo T, Rizzi G, Bertagna A, Camanni F. Ciccarelli E, et al. Among authors: bertagna a. Panminerva Med. 1987 Jul-Sep;29(3):195-202. Panminerva Med. 1987. PMID: 3696753 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters